About this trial
PRESENT is a multi-center randomised controlled trial that aims to assess whether access to pasteurized donor human milk as supplementary nutrition in the first five days of life for term infants born to women with diabetes in pregnancy reduces the proportion of infants who are admitted to a neonatal unit for management of hypoglycemia compared with current standard hospital care. The trial will also assess other important outcomes including breastfeeding rates, maternal mental health, and infant cow's milk allergy.
There will be two treatment arms. In the intervention arm, PDHM will be made available to infants from randomisation until day 5 of life. Infants allocated to the control arm will receive care as per local unit policy, including supplemental nutrition as recommended by the treating clinician. After hospital discharge, participants will be asked to complete an electronic questionnaire at 2 \& 6 weeks and 6 \& 12 months after birth. Questionnaires will assess infant feeding practices, maternal quality of life \[including anxiety and depression symptoms and health-related quality of life\] along with infant cow's milk allergy symptoms.
Eligibility criteria
Qualifiers
Mother is >18 years at the time of consent
Mother has diabetes in pregnancy (type 1, type 2 or gestational diabetes)
Mother intends to breastfeed for at least 6 weeks at the time of consent.
Infant is born at ≥ 37 weeks and weighs > 2.5kg
Disqualifiers
Multiple pregnancy
Mother has a condition that precludes maternal breast milk consumption e.g. HIV, receiving chemotherapy
Infant has clinically significant congenital abnormality interfering with effective breastfeeding or breast milk consumption (e.g., cleft lip and palate, metabolic disorder) and/or requiring immediate care in a neonatal unit (e.g., congenital heart disease).
Infant has received infant formula prior to randomisation.
Trial design
Treatments tested in this trial
- Standard care Cow's milk based formula
- Dietary Supplement: PDHM Pasteurised Donor Human Milk
Treatment groups
Sponsors and collaborators
The University of Queensland
Lead sponsor
Murdoch Childrens Research Institute
Collaborator
La Trobe University
Collaborator
University of Melbourne
Collaborator
South Australian Health and Medical Research Institute
Collaborator
Australian Red Cross Lifeblood
Collaborator
Monash University
Collaborator
The Royal Women Hospital
Collaborator
Frances Perry House (Ramsay Health)
Collaborator
Ramsay Hospital Research Foundation
Collaborator